Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

Ruxolitinib helped regrow hair in a woman with a blood disorder and complete hair loss.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

The treatment combination is effective and generally safe for lung cancer.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Vitexin Compound 1 may help reduce skin aging caused by UVA light.

Botulinum toxin-A may increase hair growth and reduce hair loss in men with baldness, and injecting near blood vessels can improve pain relief and last longer.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

Early recognition and treatment of VATS in transplant patients improve outcomes.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Bicalutamide may help treat female pattern hair loss.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Methotrexate with corticosteroids can help regrow hair in severe alopecia areata but may cause relapses and side effects.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Nobiletin-loaded vesicles effectively treat skin cancer by restoring normal miRNA and antioxidant levels.

Ruxolitinib can help regrow hair in severe alopecia areata.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Photodynamic therapy was effective in treating multiple scalp basal cell carcinomas with minimal side effects and good cosmetic results.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

Intralesional steroids are more effective for hair regrowth in alopecia areata than NBUVB, but combining them doesn't improve results.